EFFECT OF ANTIHYPERTENSIVE DEPRESCRIBING ON SERIOUS ADVERSE EVENTS, MORTALITY, AND CARDIOVASCULAR DISEASE: LONG-TERM FOLLOW-UP OF THE OPTIMISE RANDOMISED CONTROLLED TRIAL
Sheppard J., Temple E., Wang A., Smith A., Pollock S., Ford G., Hobbs R., Kenealy N., Lown M., De Lusignan S., Mant J., Mccartney D., Payne R., Williams M., Yu L-M., Mcmanus R.